Genetic Heterogeneity of Patients with Suspected Silver-Russell Syndrome: Genome-wide Copy Number Analysis in 82 Patients Without Imprinting Defects
Overview
Authors
Affiliations
Background: Silver-Russell syndrome (SRS) is a rare congenital disorder characterized by pre- and postnatal growth failure and dysmorphic features. Recently, pathogenic copy number variations (PCNVs) and imprinting defects other than hypomethylation of the -differentially methylated region (DMR) and maternal uniparental disomy chromosome 7 have been reported in patients with the SRS phenotype. This study aimed to clarify the frequency and clinical features of patients with SRS phenotype caused by PCNVs.
Methods: We performed array comparative genomic hybridization analysis using a catalog array for 54 patients satisfying the Netchine-Harbison clinical scoring system (NH-CSS) (SRS-compatible) and for 28 patients presenting with three NH-CSS items together with triangular face and/or fifth finger clinodactyly and/or brachydactyly (SRS-like) without abnormal methylation levels of 9 DMRs related to known imprinting disorders. We then investigated the clinical features of patients with PCNVs.
Results: Three of the 54 SRS-compatible patients (5.6%) and 2 of the 28 SRS-like patients (7.1%) had PCNVs. We detected 3.5 Mb deletion in 4p16.3, mosaic trisomy 18, and 3.77-4.00 Mb deletion in 19q13.11-12 in SRS-compatible patients, and 1.41-1.97 Mb deletion in 7q11.23 in both SRS-like patients. Congenital heart diseases (CHDs) were identified in two patients and moderate to severe global developmental delay was observed in four patients.
Conclusions: Of the patients in our study, 5.6% of SRS-compatible and 7.1% of SRS-like patients had PCNVs. All PCNVs have been previously reported for genetic causes of contiguous deletion syndromes or mosaic trisomy 18. Our study suggests patients with PCNVs, who have a phenotype resembling SRS, show a high tendency towards CHDs and/or apparent developmental delay.
Kosa M, Horvath E, Kalmar T, Maroti Z, Foldesi I, Bereczki C J Pediatr Genet. 2024; 13(4):320-325.
PMID: 39502855 PMC: 11534437. DOI: 10.1055/s-0042-1757621.
A long way to syndromic short stature.
Gaudioso F, Meossi C, Pezzani L, Grilli F, Silipigni R, Russo S Ital J Pediatr. 2024; 50(1):192.
PMID: 39334216 PMC: 11437795. DOI: 10.1186/s13052-024-01737-3.
Approach to the Patient With Suspected Silver-Russell Syndrome.
Kurup U, Lim D, Palau H, Maharaj A, Ishida M, Davies J J Clin Endocrinol Metab. 2024; 109(10):e1889-e1901.
PMID: 38888172 PMC: 11403326. DOI: 10.1210/clinem/dgae423.
Clinical Application of Sequential Epigenetic Analysis for Diagnosis of Silver-Russell Syndrome.
Kim S, Shin C, Lee Y, Shin C, Yang S, Cho T Ann Lab Med. 2021; 41(4):401-408.
PMID: 33536359 PMC: 7884196. DOI: 10.3343/alm.2021.41.4.401.
Rare CNVs provide novel insights into the molecular basis of GH and IGF-1 insensitivity.
Cottrell E, Cabrera C, Ishida M, Chatterjee S, Greening J, Wright N Eur J Endocrinol. 2020; 183(6):581-595.
PMID: 33055295 PMC: 7592635. DOI: 10.1530/EJE-20-0474.